Inclusion Criteria:  Those who are 19 years of age or older and 55 years of age BMI 18.5 ~ 27.5 kg/m2 Those who voluntarily agrees in writing after hearing a sufficient explanation of the purpose and procedure of the clinical trial  Exclusion Criteria:  Those with clinically significant diseases or a history of liver, kidney, cardiovascular system, endocrine system, musculoskeletal system, respiratory system, neuropsychiatric system, blood/oncology system, etc. Those with a history of gastrointestinal diseases or surgery that may affect the absorption of drugs Those who donated whole blood within 60 days from the date of eligibility assessment, or who donated component blood within 30 days Those who do not have a medically recognized contraceptive intention or plan to provide sperm from the screening date to 4 weeks from the last administration of the investigational drug Those whose blood AST, ALT, or GGT levels in the screening test exceeded 3 times the upper limit of the reference range Those who showed clinically significant results in the hepatitis B test, hepatitis C test, HIV test, and syphilis test In the case of women, those who do not show a negative response on the pregnancy test Those who judged that the investigator is not suitable for participation in clinical trials, such as showing clinically significant results in other screening tests